Authors:
Benichou, OD
Van Hul, E
Van Hul, W
de Vernejoul, MC
Citation: Od. Benichou et al., Exclusion of the chromosomal 1p2l region in a large pedigree with a phenotypic variant of type II autosomal dominant osteopetrosis, JOINT BONE, 68(4), 2001, pp. 327-333
Authors:
Grados, F
Roux, C
de Vernejoul, MC
Utard, G
Sebert, JL
Fardellone, P
Citation: F. Grados et al., Comparison of four morphometric definitions and a semiquantitative consensus reading for assessing prevalent vertebral fractures, OSTEOPOR IN, 12(9), 2001, pp. 716-722
Authors:
Bernard-Poenaru, O
Roux, C
Blanque, R
Gardner, C
de Vernejoul, MC
Cohen-Solal, ME
Citation: O. Bernard-poenaru et al., Bone-resorbing cytokines from peripheral blood mononuclear cells after hormone replacement therapy: A longitudinal study, OSTEOPOR IN, 12(9), 2001, pp. 769-776
Citation: Mc. De Vernejoul et O. Benichou, Human osteopetrosis and other sclerosing disorders: Recent genetic developments, CALCIF TIS, 69(1), 2001, pp. 1-6
Authors:
Benichou, O
Cleiren, E
Gram, J
Bollerslev, J
de Vernejoul, MC
Van Hul, W
Citation: O. Benichou et al., Mapping of autosomal dominant osteopetrosis type II (Albers-Schonberg disease) to chromosome 16p13.3, AM J HU GEN, 69(3), 2001, pp. 647-654
Authors:
Delmas, PD
Confavreux, E
Garnero, P
Fardellone, P
de Vernejoul, MC
Cormier, C
Arce, JC
Citation: Pd. Delmas et al., A combination of low doses of 17 beta-estradiol and norethisterone acetateprevents bone loss and normalizes bone turnover in postmenopausal women, OSTEOPOR IN, 11(2), 2000, pp. 177-187
Authors:
Cataisson, C
Lieberherr, M
Cros, M
Gauville, C
Graulet, AM
Cotton, J
Calvo, F
de Vernejoul, MC
Foley, J
Bouizar, Z
Citation: C. Cataisson et al., Parathyroid hormone-related peptide stimulates proliferation of highly tumorigenic human SV40-immortalized breast epithelial cells, J BONE MIN, 15(11), 2000, pp. 2129-2139
Authors:
Frayon, S
Cueille, C
Gnidehou, S
de Vernejoul, MC
Garel, JM
Citation: S. Frayon et al., Dexamethasone increases RAMP1 and CRLR mRNA expressions in human vascular smooth muscle cells, BIOC BIOP R, 270(3), 2000, pp. 1063-1067
Authors:
Lorget, F
Mentaverri, R
Meddah, B
Cayrolle, G
Wattel, A
Morel, A
Schecroun, N
Maamer, M
de Vernejoul, MC
Kamel, S
Brazier, M
Citation: F. Lorget et al., Evaluation of in vitro bone resorption: High-performance liquid chromatography measurement of the pyridinolines released in osteoclast cultures, ANALYT BIOC, 284(2), 2000, pp. 375-381
Authors:
Lips, P
Cooper, C
Agnusdei, D
Caulin, F
Egger, P
Johnell, O
Kanis, JA
Kellingray, S
Leplege, A
Liberman, UA
McCloskey, E
Minne, H
Reeve, J
Reginster, JY
Scholz, M
Todd, C
de Vernejoul, MC
Wiklund, I
Citation: P. Lips et al., Quality of life in patients with vertebral fractures: Validation of the quality of life questionnaire of the European Foundation for Osteoporosis (QUALEFFO), OSTEOPOR IN, 10(2), 1999, pp. 150-160
Authors:
Taboulet, J
Frenkian, M
Frendo, JL
Feingold, N
Jullienne, A
de Vernejoul, MC
Citation: J. Taboulet et al., Calcitonin receptor polymorphism is associated with a decreased fracture risk in post-menopausal women, HUM MOL GEN, 7(13), 1998, pp. 2129-2133